Vaccine against Porcine Circovirus type 2 | SUIGEN® PCV2
Modern and effective vaccine against Porcine Circovirus type 2 (PCV-2), formulated with genotype d and inactivated whole virus. Long-lasting protection, proven results and guaranteed animal welfare.
Update against genotype d
Advanced W/O/W adjuvant
Safety and tolerance
SUIGEN® PCV2 is a modern vaccine designed to effectively protect against Porcine Circovirus type 2 (PCV-2), especially genotype d, the most prevalent in farms today. Its formulation with inactivated whole virus ensures superior antigenic action, while its W/O/W adjuvant provides prolonged immune release.
It is a key tool for preventing both clinical and subclinical circovirosis, reducing mortality and the associated economic losses. In addition, its ready-to-use formula and excellent tolerance at the injection site make it a responsible and effective option for maintaining farm health and productivity.
3 main characteristics:
- Update against genotype d: Specifically formulated to target the predominant genotype in farms, offering higher antigenic protection.
- Advanced W/O/W adjuvant: Provides a rapid and long-lasting immune response, ensuring durable protection.
- Safety and tolerance: No significant local reactions, demonstrating responsibility toward animal welfare.
